A new offer has been made to sidestep Thermo Fisher’s $1.3 billion plan to acquire genetic analysis company Affymetrix: The company’s own former executives have banded up, with the help of a Chinese ...

Affymetrix ($AFFY), a maker of advanced genetic analysis technology, has rejected an unsolicited bid by former executives in favor of the $1.3 billion offer it ...

Thermo Fisher is to buy Affymetrix for $1.3bn and integrate the business into its Life Sciences Solutions Segment. The transaction is expected to close by the end of Q2 2016 subject to conditions, ...

Thermo Fisher Scientific Inc.TMO has finally completed the acquisition of Affymetrix Inc. on Mar 31, putting all speculations surrounding the merger to rest. This also extinguishes possibilities of a ...

Thermo Fisher Scientific has reached a deal to buy genetic analysis expert Affymetrix for $1.3 billion. The $14.00-per-share purchase price is about 50% above Affymetrix’s share price after the stock ...

A pioneer in microarray technology and a leader in genomics analysis, Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at ...

Affymetrix shareholders are set to vote on the Thermo Fisher acquisition this week, according to The New York Times. “The board of directors of Affymetrix is firmly committed to carrying out its ...

Affymetrix and its directors, executive officers and other members of its management and employees as well as Thermo Fisher and its directors and executive officers may be deemed to be participants in ...

In the wake of Thermo Fisher Scientific, Inc.'s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher's $1.3 billion takeover bid. With this ...

Jan 12 (Reuters) - Affymetrix Inc said it signed a distribution agreement with a Thermo Fisher Scientific unit for its microarray solution, GeneAtlas, throughout the United States and Canada.